Merck India has signed a Memorandum of Understanding (MoU) with Manipal Academy of Higher Education (MAHE) to strengthen academia-industry collaboration and create a future-ready talent pipeline for the healthcare sector.

As part of the partnership, Merck Healthcare R&D India launched its flagship “Catalyst” program at MAHE, a structured three-month training initiative designed to equip students with practical skills and real-world industry exposure in critical research and development domains.

The program will be delivered through MAHE’s academic ecosystem, drawing on its interdisciplinary strengths across health sciences, life sciences, and allied domains, while offering structured sessions led by Merck’s subject matter experts.

“Merck’s partnership with MAHE reflects the company’s commitment to strengthening the link between academic excellence and industry relevance, and to help students be better prepared for their professional journey. Merck has seen encouraging outcomes from similar collaborations with institutions like JSS Academy of Higher Education & Research and Dayananda Sagar University, and the company looks forward to building on that momentum with MAHE,” said Suneela Thatte, VP and Head, Merck Healthcare R&D India, who attended the signing ceremony.  

The event was also attended by Dr Sharath Rao, Pro Vice Chancellor (Health Sciences) of MAHE, and Dr. Giridhar Kini, Registrar of MAHE.  

“Collaborations such as this with Merck are integral to MAHE’s vision of building a future-ready talent ecosystem. By bringing industry closer to the classroom, we are enabling our students to engage with real-world challenges, emerging technologies, and global research practices in healthcare. The Catalyst Program is a significant step in strengthening this interface and preparing our students for impactful careers in R&D,” said Dr. Sharath Rao, Pro Vice Chancellor (Health Sciences), MAHE.